Other names: ENX-1, ENX1, KMT6, KMT6A, WVS, WVS2
Polyclonal antibody raised in rabbit against the N-terminus (aa1-343) of the mouse EZH2 protein (Enhancer of zeste homolog 2).
| Lot | 003 |
|---|---|
| Concentration | 1.0 µg/µl |
| Species reactivity | Human, mouse |
| Type | Polyclonal |
| Purity | Protein G purified |
|---|---|
| Host | Rabbit |
| Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
| Applications | Suggested dilution | References |
|---|---|---|
| ChIP * | 2 μg/ChIP | Fig 1, 2 |
| Western Blotting | 1:1,000 | Fig 3, 4 |
| Immunochemistry | 1:1000 | Fig 5 |
* Please note that of the optimal antibody amount per IP should be determined by the end-user. We recommend testing 1-5 μg per IP.

Figure 1. ChIP results obtained with the Diagenode antibody directed against EZH2
ChIP assays were performed using K562 cells, the Diagenode antibody against EZH2 (Cat. No. C15410039) and optimized PCR primer sets for qPCR. ChIP was performed with the “iDeal ChIP-seq” kit (Cat. No. C01010055), using sheared chromatin from 4 million cells. A titration of the antibody consisting of 1, 2. 5 and 10 μg per ChIP experiment was analysed. IgG (2 μg/IP) was used as negative IP control. Quantitative PCR was performed with primers for MYT1 and HOXA9, used as positive control targets, and for the coding regions of the active CCT5 and EIF2S3 genes, used as negative controls. Figure 1 shows the recovery, expressed as a % of input (the relative amount of immunoprecipitated DNA compared to input DNA after qPCR analysis).




Figure 2. ChIP-seq results obtained with the Diagenode antibody directed against EZH2
ChIP was performed on sheared chromatin from 4 million K562 cells using 2 μg of the Diagenode antibody against EZH2 (Cat. No. C15410039) as described above. The IP’d DNA was subsequently analysed on an Illumina HiSeq. Library preparation, cluster generation and sequencing were performed according to the manufacturer’s instructions. The 51 bp tags were aligned to the human genome using the BWA algorithm. Figure 2 shows the peak distribution along the short arm and a 6 Mb region containing several enriched regions of human chromosome 3 (figure 2A and B, respectively), and in two genomic regions containing the MYT1 gene on chromosome 20 and the HOX cluster on chromosome 7 (figure 2C and D).

Figure 3. Western blot analysis using the Diagenode antibody directed against EZH2
Nuclear extracts of HeLa cells (40 μg) were analysed by Western blot using the Diagenode antibody against EZH2 (Cat. No. C15410039) diluted 1:1,000 in TBS-Tween containing 5% skimmed milk. The position of the protein of interest (expected size 85 kDa) is indicated on the right; the marker (in kDa) is shown on the left.

Figure 4. Western blot analysis using the Diagenode antibody directed against EZH2
Whole cell extracts (40 μg) from HeLa cells transfected with EZH2 siRNA (lane 2) and from an untransfected control (lane 1) were analysed by Western blot using the Diagenode antibody against EZH2 (Cat. No. C15410039) diluted 1:1,000 in TBS-Tween containing 5% skimmed milk. The position of the protein of interest is indicated on the right; the marker (in kDa) is shown on the left.

Figure 5. Immunofluorescence using the Diagenode antibody directed against EZH2
HeLa cells were stained with the Diagenode antibody against EZH2 (cat. No. C15410039) and with DAPI. Cells were fixed with 4% formaldehyde for 10’ and blocked with PBS/TX-100 containing 1% BSA. The cells were immunofluorescently labelled with the EZH2 antibody (left) diluted 1:1,000 in blocking solution followed by an anti-mouse antibody conjugated to Alexa488. The middle panel shows staining of the nuclei with DAPI. A merge of the two stainings is shown on the right.
| WB Western blot : The quality of antibodies used in this technique is crucial for correct and specific protein identification. Diagenode offers huge selection of highly sensitive and specific western blot-validated antibodies. Learn more about: Load... Read more |
| IC Immunochemistry Read more |
| ChIP-seq (ab) Read more |
| ChIP-qPCR (ab) Read more |
| siRNA Knockdown Epigenetic antibodies you can trust! Antibody quality is essential for assay success. Diagenode offers antibodies that are actually validated and have been widely used and published by the scientific community. Now we are adding a new level o... Read more |
| Datasheet EZH2 pAb-039-050 DATASHEET Polyclonal antibody raised in rabbit against the N-terminus (aa1-343) of the mouse EZH2 protein (... | Download |
| Epigenetic Antibodies Brochure BROCHURE More than in any other immuoprecipitation assays, quality antibodies are critical tools in many e... | Download |
| Antibodies you can trust POSTER Epigenetic research tools have evolved over time from endpoint PCR to qPCR to the analyses of lar... | Download |
How to properly cite this product in your workDiagenode strongly recommends using this: EZH2 polyclonal antibody - Classic (Diagenode Cat# C15410039-50 Lot# 003). Click here to copy to clipboard. Using our products in your publication? Let us know! |
R-Loops Enhance Polycomb Repression at a Subset of Developmental Regulator Genes. |
Ezh2 controls development of natural killer T cells, which cause spontaneous asthma-like pathology. |
MTF2 recruits Polycomb Repressive Complex 2 by helical-shape-selective DNA binding. |
A new metabolic gene signature in prostate cancer regulated by JMJD3 and EZH2. |
STAT5BN642H is a driver mutation for T cell neoplasia |
EZH2 Histone Methyltransferase and JMJD3 Histone Demethylase Implications in Prostate Cancer |
Menin regulates Inhbb expression through an Akt/Ezh2-mediated H3K27 histone modification |
Praja1 E3 ubiquitin ligase promotes skeletal myogenesis through degradation of EZH2 upon p38α activation |
H3K4 acetylation, H3K9 acetylation and H3K27 methylation in breast tumor molecular subtypes |
Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies |
The dynamic interactome and genomic targets of Polycomb complexes during stem-cell differentiation |
MicroRNAs of the miR-290-295 Family Maintain Bivalency in Mouse Embryonic Stem Cells |
BRCA1 positively regulates FOXO3 expression by restricting FOXO3 gene methylation and epigenetic silencing through targeting EZH2 in breast cancer |
The JMJD3 Histone Demethylase and the EZH2 Histone Methyltransferase in Prostate Cancer |
Spatial Interplay between Polycomb and Trithorax Complexes Controls Transcriptional Activity in T Lymphocytes |
Loss of EZH2 results in precocious mammary gland development and activation of STAT5-dependent genes |
Polycomb repressive complex PRC1 spatially constrains the mouse embryonic stem cell genome |
H19 lncRNA controls gene expression of the Imprinted Gene Network by recruiting MBD1. |
A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma. |
The polycomb protein Ezh2 regulates differentiation and plasticity of CD4(+) T helper type 1 and type 2 cells. |
Histone lysine trimethylation or acetylation can be modulated by phytoestrogen, estrogen or anti-HDAC in breast cancer cell lines. |
Dynamic Changes in Ezh2 Gene Occupancy Underlie Its Involvement in Neural Stem Cell Self-Renewal and Differentiation towards Oligodendrocytes |
RYBP-PRC1 Complexes Mediate H2A Ubiquitylation at Polycomb Target Sites Independently of PRC2 and H3K27me3. |
PcG complexes set the stage for epigenetic inheritance of gene silencing in early S phase before replication. |
Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer. |
Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells. |
Promoter-exon relationship of H3 lysine 9, 27, 36 and 79 methylation on pluripotency-associated genes. |